Pinnacle Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,309
Closed -$386K 303
2021
Q4
$386K Buy
+6,309
New +$436K 0.12% 178

Other funds holding ARKG

Pinnacle Private Wealth's ARKG Position: Q1 2022 in Review

Pinnacle Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 6,309 shares — an estimated $386K sold.

Pinnacle Private Wealth first reported a position in ARKG in Q4 2021 and held it in 1 quarter. The position peaked at $386K in Q4 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Pinnacle Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Pinnacle Private Wealth sold 6,309 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $386K.
  • Pinnacle Private Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 1 quarter.
  • Pinnacle Private Wealth's ARK Genomic Revolution ETF position peaked at $386K in Q4 2021.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Pinnacle Private Wealth's 13F filing for Q1 2022, filed 29 Apr 2022.